Reducing injecting frequency may reduce the risk of HIV infection and improve health outcomes among injection drug users (IDU). However, the reduction of one risk behavior may be associated with an increase in other risk behaviors, including the use of other risk-associated substances. Our objective was to determine if an association exists between a reduction in injecting and level of alcohol use among IDU.
We conducted a longitudinal analysis of data collected for a randomized controlled trial examining the efficacy of a peer education intervention in reducing HIV risk among IDU and their network members in Thai Nguyen, Vietnam. Our analysis included active male injectors (n=629) who were study participants and attended both baseline and 3-month visits. Frequency of alcohol consumption was assessed as the number of alcoholic drinks in the past 30 days. Change in risk and outcome behaviors was calculated as the difference in frequencies of behaviors between baseline and 3-month follow-up visits. The outcome of interest was concurrent decreased drug injection and increased alcohol consumption.
The mean difference between baseline and 3-month follow-up of alcohol consumption and injection frequency in the past 30 days was 19.03 drinks (93.68 SD) and 20.22 injections (35.66 SD), respectively. Participants who reported reduced injection frequency were almost three times as likely to report increased alcohol consumption (OR 2.8; 95% CI, 2.0, 4.0). The proportion that both decreased injecting and increased alcohol by any amount in the past 30 days was 35.6%. In multivariate analysis higher education was significantly associated with an increase in alcohol and decrease in injecting of any amount.
Male IDU may be at risk for increasing alcohol consumption when they reduce injection frequency. Interventions with male IDU that encourage reduction of injection may need to review specific strategies to limit alcohol consumption.
Below: Change in # days consumed alcohol (y-axis) by Change in # days injected drugs (x-axis), in past 3 months: Visit2 – Visit1 = (3 months – Baseline).
Full article at: http://goo.gl/quESju
By: Vivian F. Go,a,* Nguyen Le Minh,b Constantine Frangakis,c Tran Viet Ha,a Carl A. Latkin,d Teerada Sripaipan,a Wendy Davis,a Carla Zelaya,a Nguyen Phuong Ngoc,b and Vu Minh Quana
aJohns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 615 N. Wolfe St. Baltimore, Maryland 21205 USA
bThai Nguyen Center for Preventive Medicine, Thai Nguyen, Vietnam
cJohns Hopkins Bloomberg School of Public Health, Department of Biostatistics, 615 N. Wolfe St. Baltimore, Maryland 21205 USA
dJohns Hopkins Bloomberg School of Public Health, Department of Health, Behavior and Society, 624 N. Broadway, Baltimore, Maryland 21205 USA
Corresponding Author: Vivian F. Go, PhD, MPH, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, E6610, Baltimore, MD 21205, USA, Phone: 1-215-572-5736, Fax: 1-215-616-2334, Email: ude.hpshj@ogv
More at: https://twitter.com/hiv insight